INBX
Inhibrx Biosciences, Inc. · Healthcare
Chief Executive Officer Mark Lappe bought $849K of Inhibrx Biosciences, Inc.
Bought$848,977
$84.56Price
10,040Shares
+6%Stake
What INBX did for a copier
- $1,000 copied at Thu, Oct 15 open, $87.60
- $1,066
- S&P 500, same days
- −0.8%
6 of 30 trading days so far, to the Oct 23 close.
Mark Lappe's record
3 other buys with 3 months of prices since 2024: on average −17.0% against the S&P 500, and 0 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Oct 14. Filed Wed, Oct 14, 6:58 PM ET, after the close. Returns use the Oct 15 open and the Oct 23 close. Not investment advice.